[1]
B. S. Poudyal, B. Sapkota, G. S. Shrestha, S. Thapalia, B. Gyawali, and S. Tuladhar, “Safety and Efficacy of Azathioprine as a Second Line Therapy for Primary Immune Thrombocytopenic Purpura”, J Nepal Med Assoc, vol. 55, no. 203, pp. 16–21, Sep. 2016.